It gives us immense pleasure to invite you all to the “International Congress on Frontiers in Urologic Oncology and Uropathology” - an international conference that will take place in the temple city of Bhubaneswar, Odisha, India, from 10th to 12th January, 2025, jointly organized by the Genitourinary Pathology Society, Kalinga Institute of Medical sciences, International Association for Integrated Oncology, All India Institute of Medical Sciences- Bhubaneswar, Odisha Society of Oncology, Urological Society of India – Uro-oncology Division and Medical Education Unit with the mission to foster a global community of urologic researchers and professionals, providing a platform for intellectual growth, and creating opportunities for networking and collaboration.
Indeed, this would be the first such event that will bring together world-renowned Oncologists, pathologists, and urologists, who work in the field of genitourinary oncology onto to a common platform. The academic event will be beneficial for the budding as well as practicing pathologists, urologists, and oncologists. It will also provide opportunity to physicians for meeting and networking with the stalwarts in the field of urologic oncology.
The topics covered over the three days are designed to cater to the needs of all those who are interested in urologic pathology, urology, and urologic oncology. A panel of fifteen international faculties who are the experts in their fields will grace the event which makes it a coveted one to learn about the entire realm of urologic pathology and oncology. In addition, there will be presentation and quiz for the budding physicians (trainees in pathology, urology, and oncology) which make it a much sought after event.
Register on or before 31st October 2024 to avail Early Bird Registration Fees Register Now !!
Submit your abstracts on or before 01st November 2024 Submit Now !!
Meet our International Speakers for the Conference View Now
Scientific Agenda has been Released View the Agenda
Know More about the Venue
Need Any assistance for the conference Contact Us
31st October 2024
01st November 2024
01st November 2024
AIIMS Bhubaneswar
Nadiad
USC Keck School of Medicine
UT Southwestern University
Applications of Digital and Computational Pathology and Artificial Intelligence in Genitourinary Pathology Diagnostics – Dr. Mahul B. Amin
Multiparametric MRI in Prostate Cancer Diagnosis and Management: Role of Pathologist – Dr. Cristina Magi-Galluzzi (9:15 AM-10:00 AM, 45 minutes)
Contemporary Update on Prostate Cancer Grading – Dr. Ming Zhou (10:00 AM-10:45 AM, 45 Minutes)
Prostate Cancer in the setting of low- and middle-income countries – challenges and opportunities - Dr. Mahesh Desai (11:00AM - 11:30 AM, 30 minutes)
Prostate Cancer Screening: Controversies and Consensus- The latest guidelines and evidence - Dr. Ravimohan Mavuduru (11:30 AM - 11.45 AM, 15 minutes)
Debate: PSMA PET - CT in the routine staging of prostate cancer (11:45 AM - 12:00 PM, 15 minutes)
For: Dr. Girish K. Parida
Against: Dr. Biswajit Sahoo
Expert comment: Dr. Makarand Kochikar
Oligometastatic prostate cancer: Current understanding and consensus on multi - modality management - Dr. Sandy Srinivas
Moderator : Dr. Surendra N. Senapati
Panelist :
Metastatic hormone sensitive prostate cancer : Choosing wisely - Dr.Krishna Kumar Rathnam (1:10 PM - 1:30 PM, 20 minutes)
Moderator : Dr.Sourav Mishra
Panelist (Final panelist will be notified soon)
Divergent Differentiations and Variant Histologies of Bladder Cancer – Dr. Gladell P. Paner (2:30 PM - 3:05 PM, 35 minutes)
Pathologic sub-staging of bladder cancer – updates, controversies, and guidelines – Dr. Ankur Sangoi (3:05 PM – 3:40 PM, 35 minutes)
Germ Cell Tumors of the Testis: Diagnoses that You Do Not Want to Miss – Dr. Andres M. Acosta (3:40 PM - 4:15 PM, 35 minutes)
Penile Cancer: A pathologist's perspective on current trends in diagnosis, staging, and treatment – Dr. Jasreman Dhillon (4:15 PM -4:50 PM, 35 minutes)
1) Treatment-related neuroendocrine carcinoma of the prostate (Dr. Rajal B. Shah) – 4:50 PM - 5:05 PM, 15 minutes
2) Benign mimics of urothelial carcinoma (Dr. Ankur Sangoi) – 5:05PM - 5:20 PM, 15 minutes
3) Molecularly defined renal cell carcinomas (Dr. Rohit Mehra) – 5:20PM - 5:35 PM, 15 minutes
4) Ductal adenocarcinoma of the prostate (Dr. Ming Zhou) – 5:35PM - 5:50 PM, 15 minutes
7:00 PM Onwards- Cultural program and Dinner
Keynote : Role of HPV in the management of penile cancer: Where do we stand? - Dr. Philippe E. Speiss
Large Gland Lesions of the Prostate: Current Concepts, Controversies, and Future directions – Dr. Rajal Shah (9:15 AM- 10:00 AM, 45 minutes)
How New Developments Impact Diagnosis in Existing Renal Neoplasms – Dr. Sean R. Willamson (10:00 AM- 10:45 AM, 45 minutes)
Pink Cell Tumors of the Kidney: Making Sense – Dr. Rohit Mehra (11:00 AM-11:45 AM, 45 minutes)
Best practice recommendation for immunohistochemical markers in renal cell tumors – Dr. Mahmut Akgul (11:45 AM- 12:30 PM, 45 minutes)
Case based discussion : Clear cell and papillary tumors of the kidney - Dr. Sean R. Willamson (12:30 PM - 12:45 PM, 45 minutes)
Endophytic tumors of the urinary tract - Dr. Gladell P. Paner – (12:45 PM - 1.00 PM, 15 minutes)
Sex cord-stromal tumors of the testis - Dr. Andres M. Acosta – (1:00 PM - 1:15 PM, 15 minutes)
Non-epithelial tumors of the penis Dr. Jasreman Dhillon – (2:00 PM - 2:15 PM, 15 minutes)
Mesenchymal lesions of the GU tract Dr. Mahmut Akgul – (2:15 PM - 2:30 PM, 15 minutes)
Non-muscle invasive bladder cancer: Management principles and recent advances - Dr. Makarand Kochikar (2:30 PM - 2:45 PM, 15 minutes)
Debate : Bladder Preservation Strategies in Bladder Cancer - Combined modality treatment is preferred
over Radical cystectomy in locally advanced bladder cancer (2:45 PM - 3:05 PM, 20 minutes)
Against: Dr. Manas Pradhan : 8 minutes
For: Dr. Suman Das : 8 minutes
Expert comment - Dr. Amit Ghose and Dr. Siddhartha Nanda
Neoadjuvant and adjuvant strategies in bladder cancer.
Moderator : Dr. Vineet Talwar
Panelist (Final panelist will be notified soon)
Metastatic Urothelial Carcinoma: New Horizons with emphasis on Antibody Drug Conjugates: Keynote speech: Dr. Ajjai S. Alva – (3:40 PM - 4:10 PM, 30 minutes)
Clinical management of variant histologies of bladder cancer - Dr. Bivas Biswas, (4:10 PM - 4:25 PM, 15 minutes)
1. Small renal masses: approach and Current guidelines - Dr. Ravindra Sabnis (4:25 PM - 4:40 PM, 15 minutes)
2. Sarcomatoid kidney: important diagnostic and therapeutic considerations – Keynote - Dr. Philippe E. Spiess (4:40 PM - 5:10 PM, 30 minutes)
Inauguration | Cultural program | Banquet Dinner 7 PM Onwards
1. Debate RCC: Adjuvant immunotherapy is the current standard of care in newly diagnosed RCC –
(8:30 AM - 8:50 AM, 20 minutes)
For : Dr. Manikandan Dhanushkodi
Against : Dr. Bhavesh Poladia
Expert comments : Dr. Rejiv Ranjendranath
2. Combining systemic therapy with local therapy (SBRT) in MRCC : Dr. Tanveer Shahid (8:50 AM - 9:05 AM, 15 minutes)
Moderator : Dr. Atul Sharma
Panelist (Final panelist will be notified soon)
Communicating Pathology Results for Personalized Medicine: How Are the Surgical Members of the Society of Urologic Oncology Using Pathology Reports to Guide the Treatment of Prostate Cancer Patients? - Dr. Murali Varma
Genitourinary malignancies: Making sense of Indian data with emphasis on conducting collaborative research - Dr. Atul Batra - (10:30 AM - 10:45 AM, 15 minutes)
Moderator : Dr. Shyam Agarwal
Panelist (Final panelist will be notified soon)
Concluding remarks | Valedictory | Lunch
Discover groundbreaking insights and forge connections with eminent speakers and industrialist at our conference, where innovation meets expertise for a transformative experience.
Kalinga Institute of Medical Sciences, Bhubaneshwar, Odisha, India
gupsindiaconclave@iaoncology.org
+91-8925642775
+12027548501 (USA, Canada and Others)
